Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Oncotargets and Therapy|June 20, 2019
CD48 is a key molecule of immunomodulation affecting prognosis in gliomaCunyi Zou, Chen Zhu, Gefei Guan, et al.
JCI Insight|October 18, 2022
Molecular profiling identifies distinct subtypes across TP53 mutant tumorsXin Chen, Tianqi Liu, Jianqi Wu, et al.
Oncoimmunology|August 21, 2019
Development and validation of an interferon signature predicting prognosis and treatment response for glioblastomaChen Zhu, Cunyi Zou, Gefei Guan, et al.
Neuro-Oncology|February 11, 2022
Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistanceTianqi Liu, Chen Zhu, Xin Chen, et al.
Iscience|November 3, 2022
Cancer cell intrinsic TIM-3 induces glioblastoma progressionQing Guo, Shuai Shen, Gefei Guan, et al.
Communications Biology|December 19, 2023
Tumor microenvironment remodeling plus immunotherapy could be used in mesenchymal-like tumor with high tumor residual and drug resistant rateShuai Shen, Xing Liu, Qing Guo, et al.
Frontiers in Oncology|November 16, 2020
Characterization of ROS Metabolic Equilibrium Reclassifies Pan-Cancer Samples and Guides Pathway Targeting TherapyShuai Shen, Zihao Yan, Jianqi Wu, et al.
Pageof 2